Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic's use

Diagn Microbiol Infect Dis. 2017 Mar;87(3):286-288. doi: 10.1016/j.diagmicrobio.2016.12.004. Epub 2016 Dec 16.

Abstract

We report a case of fungemia in an immunocompetent patient after administration of probiotic containing Saccharomyces boulardii. We demonstrated the strain relatedness of the yeast from the probiotic capsule and the yeast causing fungal infection using genomic and proteomic typing methods. Our study questions the safety of this preventative biotherapy.

Keywords: Fungal infection; Fungemia; Probiotic; Saccharomyces boulardii; Strain typing.

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents / therapeutic use
  • Diarrhea / drug therapy
  • Diarrhea / prevention & control
  • Fluconazole / therapeutic use
  • Fungemia / drug therapy*
  • Fungemia / microbiology*
  • Humans
  • Male
  • Middle Aged
  • Mycological Typing Techniques
  • Probiotics / adverse effects*
  • Probiotics / therapeutic use
  • Pyrimidines / therapeutic use
  • Saccharomyces boulardii / isolation & purification*
  • Sulfonamides / therapeutic use

Substances

  • Antifungal Agents
  • Pyrimidines
  • Sulfonamides
  • florasulam
  • Fluconazole